European Pharmaceutical Review

FEBRUARY 21, 2023

In this Q&A, EPR caught up with CEO James Short and Managing Director Arthur Wakeley from Celadon, to learn more about the company’s experience moving through, and progressing, the strict regulatory process for medicinal cannabis. James Short What were the key challenges for Celadon during the GMP registration process?

Pharmaceutical Companies 128

Pharmaceutical Companies Pharmaceutical Companies Compounding 128

ISPE

JUNE 27, 2023

Pound mentioned the MHRA Innovation Office , again stressing the need for early engagement. Pound said that MRAs were aligned with trade agreements, hence there could be challenges, and that ICMRA and PIC/S should be consulted by regulators as they should be helpful to the dialogue. Question: ICH Q13 was published Jan 2023.

Communication 52

Communication FDA Vaccines 52

ISPE

JUNE 26, 2023

Iacovelli stressed and Buendia concurred that digitization should be preceded by well-developed business cases that clearly define the purpose, target, and business value, then the “people aspects” of the change, and finally, the supporting technology. It must be people who make decisions about batch release.

FDA 97

FDA 97

The Thyroid Pharmacist

SEPTEMBER 2, 2022

I often get asked if there is one thing that people with Hashimoto’s should do right away to feel better. Fortunately, the new USDA MyPlate no longer encourages people to eat the equivalent of one bread loaf’s worth of carbohydrates on a daily basis! One study followed 12 people with H. My answer is always, “There are two!

Health and Personal Care Stores 98

Health and Personal Care Stores Immunization Compounding 98